Curia

Albany Molecular Research, also known as AMRI, is a chemistry-based drug discovery, development and manufacturing company that focuses on small molecule prescription drugs. Founded in 1991, the company provides chemistry-related expertise at various stages of the drug discovery process. It offers internal research programs in a number of therapeutic areas, including neurology, oncology, immune disorders and irritable bowel disease. The company provides contract chemistry-related services to various pharmaceutical and biotechnology companies. Its chemistry-related services platform includes medicinal chemistry, chemical process research and development, analytical chemistry and cGMP manufacturing. The company also has an in-house analytical chemistry department. With a location in Rensselaer, N.Y., the company maintains several proprietary technologies.